541 related articles for article (PubMed ID: 9136987)
1. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
2. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
[TBL] [Abstract][Full Text] [Related]
3. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
4. Activation of epidermal akt by diverse mouse skin tumor promoters.
Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
[TBL] [Abstract][Full Text] [Related]
7. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes.
Piepkorn M; Predd H; Underwood R; Cook P
Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307
[TBL] [Abstract][Full Text] [Related]
8. Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways.
Klein SB; Fisher GJ; Jensen TC; Mendelsohn J; Voorhees JJ; Elder JT
J Cell Physiol; 1992 May; 151(2):326-36. PubMed ID: 1572907
[TBL] [Abstract][Full Text] [Related]
9. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
10. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor.
Muthuswamy SK; Muller WJ
Oncogene; 1995 Jul; 11(2):271-9. PubMed ID: 7542762
[TBL] [Abstract][Full Text] [Related]
11. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
13. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling.
Scheving LA; Zhang L; Stevenson MC; Kwak ES; Russell WE
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G16-25. PubMed ID: 16769812
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.
Li J; Ma C; Huang Y; Luo J; Huang C
Oncogene; 2003 Jan; 22(2):211-9. PubMed ID: 12527890
[TBL] [Abstract][Full Text] [Related]
15. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
16. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
17. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2.
Gulliford TJ; Huang GC; Ouyang X; Epstein RJ
Oncogene; 1997 Oct; 15(18):2219-23. PubMed ID: 9393980
[TBL] [Abstract][Full Text] [Related]
18. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
Piazza GA; Ritter JL; Baracka CA
Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
[TBL] [Abstract][Full Text] [Related]
20. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
Ahmad N; Gali H; Javed S; Agarwal R
Biochem Biophys Res Commun; 1998 Jun; 247(2):294-301. PubMed ID: 9642119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
